We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Outlines Clinical Pharmacology Considerations in Pediatric Trials
FDA Outlines Clinical Pharmacology Considerations in Pediatric Trials
Sponsors submitting pediatric study plans should consider whether a product affects adults and children similarly when choosing an approach, the FDA says.